Heart Beat – December 2023


Progress in Treating Obesity-Related Hypertension

In early trials, the novel investigational medication lorundrostat significantly lowered aldosterone production and safely lowered blood pressure in individuals with uncontrolled hypertension. It was particularly effective in those with obesity.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access